Designed and manufactured by EchoNous in Redmond, Washington, Kosmos is the only ultra-mobile handheld POCUS device that combines diagnostic-grade imaging with continuous-wave Doppler capability. Kosmos’ AI-driven system enables semi-automated assessment of systolic heart function at bedside and is marketed under FDA’s COVID enforcement policy as an assistive tool for the detection and treatment of COVID-19. Paired with its Torso probe, Kosmos is rapidly emerging as a tool of choice for cardiologists and critical care practitioners. With Lexsa, the platform’s newly released 128-channel linear probe, Kosmos produces high-quality nerve, lung, vascular and musculoskeletal ultrasound images.
